Search Results - A. B. Verveda

Optimisation of Approaches to Adverse Event Analysis in Bioequivalence Clinical Trials by A. B. Verveda, V. B. Vasilyuk, G. I. Syraeva, M. V. Faraponova

Connect to this object online.

Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System by M. A. Zaytseva, M. B. Ivanov, A. B. Verveda, L. V. Lyanginen

Connect to this object online.

Assessment of the influence of demographic and anthropometric indicators on the variability of pharmacokinetic parameters by V. B. Vasilyuk, A. B. Verveda, M. V. Faraponova, G. I. Syraeva

Connect to this object online.

Comparative evaluation of safety parameters at the preclinical and clinical stages of the study of the Reamberin® (LLC "POLYSAN") by V. B.  Vasilyuk, M. V. Faraponova, G. I. Syraeva, A. B. Verveda, A. V. Belskaya, A.  V. Shults, L. G. Kubarskaya, E. A. Zolotoverkhaya

Connect to this object online.

Individual features of the pharmacokinetics of fludarabin phosphate in the treatment of patients with chronic lymphocytic leukemia by G. G. Rodionov, I. I. Shantyr, V. B. Vasilyuk, E. A. Kolobova, E. V. Svetkina, M. V. Faraponova, A. B. Verveda, G. I. Syraeva, K. A. Zakharov

Connect to this object online.